GH and IGF-1 levels gradually return to baseline, and any enhanced benefitslike improved recovery or body compositionmay diminish over time
Toyoshima K, Araki A, Tamura Y, Iritani O, Ogawa S, Kozaki K, et al
The Phase 2 diabetes trial reported HbA1c reductions of up to 2.02% at the 12 mg dose, alongside 16.9% weight loss
Typically, treatments are administered weekly or bi-weekly to maintain optimal results and support your weight loss journey
This premium lyophilized blend combines CJC-1295 No DAC (Modified GRF 1-29) and Ipamorelin to create a synergistic research tool for the investigation of the Growth Hormone (GH) axis
Monthly body composition assessments provide adequate resolution to detect meaningful changes while avoiding over-interpretation of measurement noise